Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
23 October, 2018 15:37 IST
Fitch withdraws ratings assigned to Rcom
Source: IRIS | 06 Dec, 2017, 10.08AM
Comments  |  Post Comment

Fitch Ratings has withdrawn India-based Reliance Communications (Rcom) Long-Term Foreign- and Local-Currency Issuer Default Ratings (IDR) of 'Restricted Default' (RD) and the rating on Rcom's USD 300 million 6.5% senior secured notes due 2020 of 'C' with Recovery Rating of 'RR4'.

The stock had underperformed the market over the past one month till Dec. 05, 2017, falling 31.72% compared with the Sensex's 2.62% decline. It underperformed the market in past one quarter, declining 49.39% as against 3.12% rise in the Sensex.

Shares of the company declined Rs 0.17, or 1.5%, to trade at Rs 11.17. The total volume of shares traded was 691,343 at the BSE (9.59 a.m., Wednesday).



Reliance Communications Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Zydus receives final approval from USFDA for Clobazam Tablets - 23-Oct-2018 15:01
Ahluwalia Contracts wins new orders of worth Rs 5.38 bn - 23-Oct-2018 11:58
PNB Housing Finance raises Rs 17.75 bn through commercial papers - 23-Oct-2018 10:22
White Organic Agro bags additional orders from Innovative Cuisine - 23-Oct-2018 10:16
Himachal Futuristic Communications secures order worth Rs 3.66 bn - 23-Oct-2018 10:07
Lupin gets nod for generic Triamcinolone Acetonide ointment - 23-Oct-2018 10:00
ITD Cementation India bags orders worth Rs 10.66 bn - 23-Oct-2018 09:35
Biocon, Mylan announce positive CHMP Opinion for Ogivri - 22-Oct-2018 10:28
Lupin announces positive CHMP opinion for NaMuscla - 22-Oct-2018 09:51
Tejas Networks bags Rs 1.11 bn order from Sterlite Technologies - 22-Oct-2018 09:45
Alembic Pharma' JV completes USFDA inspection of Karakhadi unit - 22-Oct-2018 09:41
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer